The effect of aging on cellular immunity against cancer in SR/CR mice

Cancer Immunology, Immunotherapy

Volumn 53, Issue 6, 2004, Pages 473-478

  Cui, Zheng ^a   Willingham, Mark C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer and aging; Immune surveillance; Innate immunity; Spontaneous regression

Indexed keywords

CANCER CELL; CANCER IMMUNOLOGY; CELL AGING; CELL TRANSPLANTATION; CELLULAR IMMUNITY; EFFECTOR CELL; IMMUNE SYSTEM; LEUKOCYTE; LIFESPAN; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AGING; ANIMALS; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC SURVEILLANCE; MICE; MICE, INBRED STRAINS; NEOPLASMS, EXPERIMENTAL;

EID: 2542490532     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0488-2     Document Type: Review

References (31)

1. Brüünsgaard H, Pedersen BK (2003) Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23:15
2. Burnet FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13:1
3. Caruso RA, Speciale G, Inferrera C (1994) Neutrophil interaction with tumour cells in small early gastric cancer: ultra-structural observations. Histol Histopathol 9:295
4. Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W, DeLong CJ (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A 100:6682
5. Dallegri F, Ottonello L (1992) Neutrophil-mediated cytotoxicity against tumour cells: state of art. Arch Immunol Ther Exp (Warsz) 40:39
6. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW (1999) Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand 100:34
7. Drapier JC, Hibbs JB (1986) Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 78:790
8. Drapier JC, Hibbs JB (1988) Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 140:2829
9. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991
10. Ehrlich P (1909) Ueber den jetzigen stand der Karzinomforschung. Ned Tijdschr Geneeskd 5:273
11. Engel AM, Svane IM, Rygaard J, Werdelin O (1997) MCA sarcomas induced in seid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice. Scand J Immunol 45:463
12. Fryling CM, Iwata KK, Johnson PA, Knott WB, Todaro GJ (1985) Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line. Cancer Res 45:2695
13. Hibbs JB, Taintor RR (1986) Activated macrophage-mediated cytotoxicity: use of the in vitro cytotoxicity assay for study of bioenergetic and biochemical changes that develop in tumor target cells. Methods Enzymol 132:508
14. Hibbs JB, Taintor RR, Vavrin Z (1984) Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun 123:716
15. Hunig T (1983) T-cell function and specificity in athymic mice. Immunol Today 4:84
16. Ikehara S, Pahwa RN, Fernandes G, Hansen CT, Good RA (1984) Functional T cells in athymic nude mice. Proc Natl Acad Sci U S A 81:886
17. Maleckar JR, Sherman LA (1987) The composition of the T cell receptor repertoire in nude mice. J Immunol 138:3873
18. Mizel SB, DeLarco JE, Todaro GJ, Farrar WL, Hilfiker ML (1980) In vitro production of immunosuppressive factors by murine sarcoma virus-transformed mouse fibroblasts. Proc Natl Acad Sci U S A 77:2205
19. Romeo DS, Mizel SB (1989) Partial purification of an immunosuppressive protein from a human tumor cell line and analysis of its relationship to transforming growth factor beta. Cell Immunol 122: 483
20. Rygaard J, Povlsen CO (1974) Is immunological surveillance not a cell-mediated immune function? Transplantation 17:135
21. Rygaard J, Povlsen CO (1974) The mouse mutant nude does not develop spontaneous tumours: an argument against immunological surveillance. Acta Pathol Microbiol Scand [B] Microbiol Immunol 82:99
22. Shah AH, Lee C (2000) TGF-beta-based immunotherapy for cancer: breaching the tumor firewall. Prostate 45:167
23. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107
24. Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ (1983) High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 43:403
25. Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661
26. Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755
27. Stutman O (1978) In: Fogh J, Giovanella BC (eds) The nude mouse in experimental and clinical research. Academic, New York, pp 411-435
28. Stutman O (1979) Spontaneous tumors in nude mice: effect of the viable yellow gene. Exp Cell Biol 47:129
29. Thomas L (1959) In: Lawrence HS (ed) Cellular and humoral aspects of the hypersensitive states. Hoeber-Harper, New York, pp 529-532
30. Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB, Samlowski WE (1995) Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. J Immunol 155:4382
31. Yoshida M, Matsuzaki H, Sakata K, Takeya M, Kato K, Mizushima S, Kawakita M, Takatsuki K (1992) Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma. Cancer Res 52:464